Jamie Tsung

Company: Alnylam Pharmaceuticals

Job title: Director DP Formulation & CMC

Bio:

Jamie Tsung is a pharmaceutical and biotech leader with deep CMC and Drug Product development expertise, spanning the full lifecycle from preclinical to commercial stages across small molecules, nucleic acids, and protein-based therapeutics. Known for blending scientific rigor with creative problem-solving, she has authored or reviewed over 50 CMC regulatory sections and is recognized for integrating formulation science, analytical methods, and processing technologies to deliver innovative, compliant solutions.

Seminars:

Roundtable Discussion: Not All Modalities Are Created Equal: Overcoming Formulation Challenges in Intrathecal Delivery to Speed CMC & Improve Patient Outcomes 11:40 am

How do different modalities uniquely challenge formulation for safe and effective intrathecal delivery? What formulation strategies – buffers, excipients, conjugates – are proving most effective or problematic for IT delivery of ASOs and siRNAs? What are regulators looking for in safe and scalable IT formulations, and how can we align preclinical testing with clinical expectations?…Read more

day: Day One - Morning - Track B